AdaptHealth Q1 2024 GAAP EPS $(0.02) May Not Be Comparable To $0.05 Estimate, Sales $792.497M Beat $769.867M Estimate
AdaptHealth Q1 2024 GAAP EPS $(0.02) May Not Be Comparable To $0.05 Estimate, Sales $792.497M Beat $769.867M Estimate
AdaptHealth 2024 年第一季度的 GAAP 每股收益 (0.02) 可能無法與預期的0.05美元相提並論，銷售額7.92497億美元超過預期的7.69867億美元
AdaptHealth (NASDAQ:AHCO) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.05 by 140 percent. The company reported quarterly sales of $792.497 million which beat the analyst consensus estimate of $769.867 million by 2.94 percent. This is a 6.43 percent increase over sales of $744.626 million the same period last year.
AdaptHealth（納斯達克股票代碼：AHCO）公佈的季度虧損爲每股0.02美元，比分析師普遍預期的0.05美元低140％。該公司公佈的季度銷售額爲7.92497億美元，比分析師普遍預期的7.69867億美元高出2.94％。這比去年同期的7.44626億美元的銷售額增長了6.43％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。